A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS

NCT04602104 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: low dose hMSC-Exos
BIOLOGICAL: medium dose hMSC-Exos
BIOLOGICAL: high dose hMSC-Exos
BIOLOGICAL: Dosage 1of hMSC-Exos
BIOLOGICAL: Dosage 2 of hMSC-Exos
BIOLOGICAL: No hMSC-derived exosomes

Sponsor

Ruijin Hospital

Collaborators

[object Object]